Skip to Main Content

Author Details

Marie Paule Schneider
School of Pharmaceutical Sciences, University of Geneva
1998
74
17
PMIDPaper TitleJournal TitlePublished Year
36612312Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.Cancers (Basel)2023
36818412Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes.Diabetes Spectr2023
37260208[The prescription: messenger between the person, the doctor's office, the nursing and pharmacy teams].Rev Med Suisse2023
37260204[Diabetic nephropathy: Interprofessional support of medication adherence].Rev Med Suisse2023
36877813Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care.J Contin Educ Health Prof2023
36612312Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.Cancers (Basel)2023
37260208[The prescription: messenger between the person, the doctor's office, the nursing and pharmacy teams].Rev Med Suisse2023
37260204[Diabetic nephropathy: Interprofessional support of medication adherence].Rev Med Suisse2023
36818412Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes.Diabetes Spectr2023
36877813Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care.J Contin Educ Health Prof2023
34993650Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.Support Care Cancer2022
36046500Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.Patient Prefer Adherence2022
36034792Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.Front Pharmacol2022
35890213Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.Pharmaceutics2022
36328384Patients' perceptions of conflicting information on chronic medications: a prospective survey in Switzerland.BMJ Open2022
35779984Motivational interviewing to support medication adherence in adults with chronic conditions: Systematic review of randomized controlled trials.Patient Educ Couns2022
34993650Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.Support Care Cancer2022
35779984Motivational interviewing to support medication adherence in adults with chronic conditions: Systematic review of randomized controlled trials.Patient Educ Couns2022
36046500Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.Patient Prefer Adherence2022
36034792Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.Front Pharmacol2022
36328384Patients' perceptions of conflicting information on chronic medications: a prospective survey in Switzerland.BMJ Open2022
35890213Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.Pharmaceutics2022
32266825Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence.AIDS Care2021
32266825Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence.AIDS Care2021
34077041[Hospital to home transition of care: challenges for patients with type 2 diabetes].Rev Med Suisse2021
33739292Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS).JMIR Res Protoc2021
33604408Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study.Open Forum Infect Dis2021
33603005Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study.Sci Rep2021
34307726Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication.Open Forum Infect Dis2021
34185020Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.JMIR Res Protoc2021
35047896Digital Medication Adherence Support: Could Healthcare Providers Recommend Mobile Health Apps?Front Med Technol2021
33603005Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study.Sci Rep2021
33739292Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS).JMIR Res Protoc2021
33604408Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study.Open Forum Infect Dis2021
35047896Digital Medication Adherence Support: Could Healthcare Providers Recommend Mobile Health Apps?Front Med Technol2021
34185020Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.JMIR Res Protoc2021
34077041[Hospital to home transition of care: challenges for patients with type 2 diabetes].Rev Med Suisse2021
34307726Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication.Open Forum Infect Dis2021
31479043Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.Ther Drug Monit2020
31721271The ABC taxonomy for medication adherence translated into French and German.Br J Clin Pharmacol2020
32520461[Medication adherence and physician-pharmacist collaboration. Focus on the patient with diabetic nephropathy].Rev Med Suisse2020
32913876An Adherence-Enhancing Program Increases Retention in Care in the Swiss HIV Cohort.Open Forum Infect Dis2020
32631634Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients.Clin Ther2020
31479043Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.Ther Drug Monit2020
31721271The ABC taxonomy for medication adherence translated into French and German.Br J Clin Pharmacol2020
32913876An Adherence-Enhancing Program Increases Retention in Care in the Swiss HIV Cohort.Open Forum Infect Dis2020
32631634Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients.Clin Ther2020
32520461[Medication adherence and physician-pharmacist collaboration. Focus on the patient with diabetic nephropathy].Rev Med Suisse2020
30621697Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?BMC Health Serv Res2019
31776778Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results.Int J Clin Pharm2019
  • 1 - 50 of 148

Recommended Authors

Cedars-Sinai Medical Center
Career Start Year 2017
Number of shared co-authors 0
Section of Hospital Medicine, Vanderbilt University Medical Center
Career Start Year 2014
Number of shared co-authors 0
Department of Pharmacy Practice, 2University of Kansas School of Pharmacy
Career Start Year 2012
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 0
Stanford University
Career Start Year 2010
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 2009
Number of shared co-authors 0
Department of Pharmacotherapy & Outcomes Science
Career Start Year 2008
Number of shared co-authors 0
College of Public Health, Taipei Medical University
Career Start Year 2004
Number of shared co-authors 0
Lipscomb University
Career Start Year 2004
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 0
St. Jude Children's Research Hospital Memphis
Career Start Year 2003
Number of shared co-authors 0
Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center
Career Start Year 2001
Number of shared co-authors 0
37345National Center for Health Statistics
Career Start Year 2000
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 1
School of Pharmacy, University of Maryland
Career Start Year 2000
Number of shared co-authors 0
University of Wisconsin
Career Start Year 1998
Number of shared co-authors 0
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 1996
Number of shared co-authors 1
University of Massachusetts Chan Medical School
Career Start Year 1996
Number of shared co-authors 0
Institute of General Practice and Family Medicine, University Hospital
Career Start Year 1996
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 1996
Number of shared co-authors 0
Section of Hospital Medicine, Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 0
Tulane University School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Duke University
Career Start Year 1990
Number of shared co-authors 0
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 0
Fielding School of Public Health, University of California los angeles
Career Start Year 1981
Number of shared co-authors 1
School of Pharmacy, University of Washington
Career Start Year 1980
Number of shared co-authors 1
The University of New Mexico
Career Start Year 1977
Number of shared co-authors 0
Lee Kong Chian School of Medicine, Nanyang Technological University
Career Start Year 1975
Number of shared co-authors 0
University of Colorado
Career Start Year 1975
Number of shared co-authors 0

Collaborators

Community Pharmacy, School of Pharmaceutical Sciences, University of Geneva
Co-authored papers 37
Lausanne University Hospital, University of Lausanne
Co-authored papers 20
Community pharmacy, University of Lausanne
Co-authored papers 6
Vir Biotechnology Inc.
Co-authored papers 1
Institute of Medical Virology, University of Zurich
Co-authored papers 1
Institute of Nursing Science, University of Basel
Co-authored papers 1
University of Bristol
Co-authored papers 1
Co-authored papers 1
IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Co-authored papers 1
University of California los angeles
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Co-authored papers 1